Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 2001 Apr;80(4):1769–1782. doi: 10.1016/S0006-3495(01)76147-4

Arg(615)Cys substitution in pig skeletal ryanodine receptors increases activation of single channels by a segment of the skeletal DHPR II-III loop.

E M Gallant 1, S Curtis 1, S M Pace 1, A F Dulhunty 1
PMCID: PMC1301366  PMID: 11259290

Abstract

The effect of peptides, corresponding to sequences in the skeletal muscle dihydropyridine receptor II-III loop, on Ca(2+) release from sarcoplasmic reticulum (SR) and on ryanodine receptor (RyR) calcium release channels have been compared in preparations from normal and malignant hyperthermia (MH)-susceptible pigs. Peptide A (Thr(671)-Leu(690); 36 microM) enhanced the rate of Ca(2+) release from normal SR (SR(N)) and from SR of MH-susceptible muscle (SR(MH)) by 10 +/- 3.2 nmole/mg/min and 76 +/- 9.7 nmole/mg/min, respectively. Ca (2+) release from SR(N) or SR(MH) was not increased by control peptide NB (Gly(689)-Lys(708)). AS (scrambled A sequence; 36 microM) did not alter Ca (2+) release from SR(N), but increased release from SR(MH) by 29 +/- 4.9 nmoles/mg/min. RyR channels from MH-susceptible muscle (RyR(MH)) were up to about fourfold more strongly activated by peptide A (> or =1 nM) than normal RyR channels (RyR(N)) at -40 mV. Neither NB or AS activated RyR(N). RyR(MH) showed an approximately 1.8-fold increase in mean current with 30 microM AS. Inhibition at +40 mV was stronger in RyR(MH) and seen with peptide A (> or = 0.6 microM) and AS (> or = 0.6 microM), but not NB. These results show that the Arg(615)Cys substitution in RyR(MH) has multiple effects on RyRs. We speculate that enhanced DHPR activation of RyRs may contribute to increased Ca(2+) release from SR in MH-susceptible muscle.

Full Text

The Full Text of this article is available as a PDF (193.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhat M. B., Zhao J., Takeshima H., Ma J. Functional calcium release channel formed by the carboxyl-terminal portion of ryanodine receptor. Biophys J. 1997 Sep;73(3):1329–1336. doi: 10.1016/S0006-3495(97)78166-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Casarotto M. G., Gibson F., Pace S. M., Curtis S. M., Mulcair M., Dulhunty A. F. A structural requirement for activation of skeletal ryanodine receptors by peptides of the dihydropyridine receptor II-III loop. J Biol Chem. 2000 Apr 21;275(16):11631–11637. doi: 10.1074/jbc.275.16.11631. [DOI] [PubMed] [Google Scholar]
  3. Chaudhari N. A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice. J Biol Chem. 1992 Dec 25;267(36):25636–25639. [PubMed] [Google Scholar]
  4. Dulhunty A. F., Laver D. R., Gallant E. M., Casarotto M. G., Pace S. M., Curtis S. Activation and inhibition of skeletal RyR channels by a part of the skeletal DHPR II-III loop: effects of DHPR Ser687 and FKBP12. Biophys J. 1999 Jul;77(1):189–203. doi: 10.1016/S0006-3495(99)76881-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. El-Hayek R., Ikemoto N. Identification of the minimum essential region in the II-III loop of the dihydropyridine receptor alpha 1 subunit required for activation of skeletal muscle-type excitation-contraction coupling. Biochemistry. 1998 May 12;37(19):7015–7020. doi: 10.1021/bi972907o. [DOI] [PubMed] [Google Scholar]
  6. Fill M., Stefani E., Nelson T. E. Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle. Biophys J. 1991 May;59(5):1085–1090. doi: 10.1016/S0006-3495(91)82323-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fujii J., Otsu K., Zorzato F., de Leon S., Khanna V. K., Weiler J. E., O'Brien P. J., MacLennan D. H. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science. 1991 Jul 26;253(5018):448–451. doi: 10.1126/science.1862346. [DOI] [PubMed] [Google Scholar]
  8. Gallant E. M., Godt R. E., Gronert G. A. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs. J Pharmacol Exp Ther. 1980 Apr;213(1):91–96. [PubMed] [Google Scholar]
  9. Gurrola G. B., Arévalo C., Sreekumar R., Lokuta A. J., Walker J. W., Valdivia H. H. Activation of ryanodine receptors by imperatoxin A and a peptide segment of the II-III loop of the dihydropyridine receptor. J Biol Chem. 1999 Mar 19;274(12):7879–7886. doi: 10.1074/jbc.274.12.7879. [DOI] [PubMed] [Google Scholar]
  10. Haarmann C. S., Fink R. H., Dulhunty A. F. Oxidation and reduction of pig skeletal muscle ryanodine receptors. Biophys J. 1999 Dec;77(6):3010–3022. doi: 10.1016/S0006-3495(99)77132-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hogan K., Powers P. A., Gregg R. G. Cloning of the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics. 1994 Dec;24(3):608–609. doi: 10.1006/geno.1994.1677. [DOI] [PubMed] [Google Scholar]
  12. Jurkat-Rott K., McCarthy T., Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve. 2000 Jan;23(1):4–17. doi: 10.1002/(sici)1097-4598(200001)23:1<4::aid-mus3>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  13. Kim D. H., Sreter F. A., Ohnishi S. T., Ryan J. F., Roberts J., Allen P. D., Meszaros L. G., Antoniu B., Ikemoto N. Kinetic studies of Ca2+ release from sarcoplasmic reticulum of normal and malignant hyperthermia susceptible pig muscles. Biochim Biophys Acta. 1984 Sep 5;775(3):320–327. doi: 10.1016/0005-2736(84)90187-1. [DOI] [PubMed] [Google Scholar]
  14. Lamb G. D., Stephenson D. G. Effect of Mg2+ on the control of Ca2+ release in skeletal muscle fibres of the toad. J Physiol. 1991 Mar;434:507–528. doi: 10.1113/jphysiol.1991.sp018483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Laver D. R., Owen V. J., Junankar P. R., Taske N. L., Dulhunty A. F., Lamb G. D. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia. Biophys J. 1997 Oct;73(4):1913–1924. doi: 10.1016/S0006-3495(97)78222-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leong P., MacLennan D. H. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor. J Biol Chem. 1998 Apr 3;273(14):7791–7794. doi: 10.1074/jbc.273.14.7791. [DOI] [PubMed] [Google Scholar]
  17. Loke J., MacLennan D. H. Malignant hyperthermia and central core disease: disorders of Ca2+ release channels. Am J Med. 1998 May;104(5):470–486. doi: 10.1016/s0002-9343(98)00108-9. [DOI] [PubMed] [Google Scholar]
  18. Lopez J. R., Alamo L. A., Jones D. E., Papp L., Allen P. D., Gergely J., Sréter F. A. [Ca2+]i in muscles of malignant hyperthermia susceptible pigs determined in vivo with Ca2+ selective microelectrodes. Muscle Nerve. 1986 Jan;9(1):85–86. [PubMed] [Google Scholar]
  19. Lu X., Xu L., Meissner G. Activation of the skeletal muscle calcium release channel by a cytoplasmic loop of the dihydropyridine receptor. J Biol Chem. 1994 Mar 4;269(9):6511–6516. [PubMed] [Google Scholar]
  20. Lu X., Xu L., Meissner G. Phosphorylation of dihydropyridine receptor II-III loop peptide regulates skeletal muscle calcium release channel function. Evidence for an essential role of the beta-OH group of Ser687. J Biol Chem. 1995 Aug 4;270(31):18459–18464. doi: 10.1074/jbc.270.31.18459. [DOI] [PubMed] [Google Scholar]
  21. Lynch P. J., Tong J., Lehane M., Mallet A., Giblin L., Heffron J. J., Vaughan P., Zafra G., MacLennan D. H., McCarthy T. V. A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4164–4169. doi: 10.1073/pnas.96.7.4164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ma J. Desensitization of the skeletal muscle ryanodine receptor: evidence for heterogeneity of calcium release channels. Biophys J. 1995 Mar;68(3):893–899. doi: 10.1016/S0006-3495(95)80265-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mead F. C., Sullivan D., Williams A. J. Evidence for negative charge in the conduction pathway of the cardiac ryanodine receptor channel provided by the interaction of K+ channel N-type inactivation peptides. J Membr Biol. 1998 Jun 1;163(3):225–234. doi: 10.1007/s002329900386. [DOI] [PubMed] [Google Scholar]
  24. Meissner G. Adenine nucleotide stimulation of Ca2+-induced Ca2+ release in sarcoplasmic reticulum. J Biol Chem. 1984 Feb 25;259(4):2365–2374. [PubMed] [Google Scholar]
  25. Mickelson J. R., Gallant E. M., Litterer L. A., Johnson K. M., Rempel W. E., Louis C. F. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem. 1988 Jul 5;263(19):9310–9315. [PubMed] [Google Scholar]
  26. Mickelson J. R., Louis C. F. Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects. Physiol Rev. 1996 Apr;76(2):537–592. doi: 10.1152/physrev.1996.76.2.537. [DOI] [PubMed] [Google Scholar]
  27. Nakai J., Tanabe T., Konno T., Adams B., Beam K. G. Localization in the II-III loop of the dihydropyridine receptor of a sequence critical for excitation-contraction coupling. J Biol Chem. 1998 Sep 25;273(39):24983–24986. doi: 10.1074/jbc.273.39.24983. [DOI] [PubMed] [Google Scholar]
  28. Ohta T., Endo M., Nakano T., Morohoshi Y., Wanikawa K., Ohga A. Ca-induced Ca release in malignant hyperthermia-susceptible pig skeletal muscle. Am J Physiol. 1989 Feb;256(2 Pt 1):C358–C367. doi: 10.1152/ajpcell.1989.256.2.C358. [DOI] [PubMed] [Google Scholar]
  29. Otsu K., Nishida K., Kimura Y., Kuzuya T., Hori M., Kamada T., Tada M. The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia. J Biol Chem. 1994 Apr 1;269(13):9413–9415. [PubMed] [Google Scholar]
  30. Otsu K., Phillips M. S., Khanna V. K., de Leon S., MacLennan D. H. Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia. Genomics. 1992 Jul;13(3):835–837. doi: 10.1016/0888-7543(92)90163-m. [DOI] [PubMed] [Google Scholar]
  31. Owen V. J., Taske N. L., Lamb G. D. Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia. Am J Physiol. 1997 Jan;272(1 Pt 1):C203–C211. doi: 10.1152/ajpcell.1997.272.1.C203. [DOI] [PubMed] [Google Scholar]
  32. Richter M., Schleithoff L., Deufel T., Lehmann-Horn F., Herrmann-Frank A. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem. 1997 Feb 21;272(8):5256–5260. doi: 10.1074/jbc.272.8.5256. [DOI] [PubMed] [Google Scholar]
  33. Sagara Y., Inesi G. Inhibition of the sarcoplasmic reticulum Ca2+ transport ATPase by thapsigargin at subnanomolar concentrations. J Biol Chem. 1991 Jul 25;266(21):13503–13506. [PubMed] [Google Scholar]
  34. Shomer N. H., Louis C. F., Fill M., Litterer L. A., Mickelson J. R. Reconstitution of abnormalities in the malignant hyperthermia-susceptible pig ryanodine receptor. Am J Physiol. 1993 Jan;264(1 Pt 1):C125–C135. doi: 10.1152/ajpcell.1993.264.1.C125. [DOI] [PubMed] [Google Scholar]
  35. Takeshima H., Nishimura S., Matsumoto T., Ishida H., Kangawa K., Minamino N., Matsuo H., Ueda M., Hanaoka M., Hirose T. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 1989 Jun 8;339(6224):439–445. doi: 10.1038/339439a0. [DOI] [PubMed] [Google Scholar]
  36. Tanabe T., Beam K. G., Adams B. A., Niidome T., Numa S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature. 1990 Aug 9;346(6284):567–569. doi: 10.1038/346567a0. [DOI] [PubMed] [Google Scholar]
  37. Tanabe T., Takeshima H., Mikami A., Flockerzi V., Takahashi H., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature. 1987 Jul 23;328(6128):313–318. doi: 10.1038/328313a0. [DOI] [PubMed] [Google Scholar]
  38. Timerman A. P., Ogunbumni E., Freund E., Wiederrecht G., Marks A. R., Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J Biol Chem. 1993 Nov 5;268(31):22992–22999. [PubMed] [Google Scholar]
  39. Tong J., McCarthy T. V., MacLennan D. H. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels. J Biol Chem. 1999 Jan 8;274(2):693–702. doi: 10.1074/jbc.274.2.693. [DOI] [PubMed] [Google Scholar]
  40. Tong J., Oyamada H., Demaurex N., Grinstein S., McCarthy T. V., MacLennan D. H. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease. J Biol Chem. 1997 Oct 17;272(42):26332–26339. doi: 10.1074/jbc.272.42.26332. [DOI] [PubMed] [Google Scholar]
  41. Tripathy A., Resch W., Xu L., Valdivia H. H., Meissner G. Imperatoxin A induces subconductance states in Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle. J Gen Physiol. 1998 May;111(5):679–690. doi: 10.1085/jgp.111.5.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. el-Hayek R., Antoniu B., Wang J., Hamilton S. L., Ikemoto N. Identification of calcium release-triggering and blocking regions of the II-III loop of the skeletal muscle dihydropyridine receptor. J Biol Chem. 1995 Sep 22;270(38):22116–22118. doi: 10.1074/jbc.270.38.22116. [DOI] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES